 So it's just one of those deals that in my mind says, yeah, the system does work, but perhaps not far enough. Purdue Pharma said it may not survive if the Chapter 11 plan were rejected and that victims of opioid addiction would face additional delays and uncertainty in receiving compensation. That's the argument that they were using to not being sued.